Featured Articles
-
Early Product Characterization De-Risks Biologics Development
6/12/2019
The relationship between physicochemical profile and biological activity — and how this relationship affects clinical performance — is key to informed decisions, accelerated development, and risk reduction.
-
Data Integrity And Traceability In Sterility Testing
11/19/2026
A sterility result is only as defensible as the history behind it, and a QA lead, a QC microbiology manager and a solution provider disagree on what that history should capture and how.
-
Strategies For Efficiency, Scalability, And Process Performance
11/12/2026
Single-use adoption, automation, and digital modeling shape how biologics are made. Several perspectives suggest that structure, data discipline, and internal standards often matter more.
-
Advancing Downstream Purification
11/4/2026
Aggregate and variant clearance for bispecifics, ADCs, and fusion proteins looks different with frontal-mode cation exchange and mixed-mode selectivity, including fewer process steps.
-
Chromatography Resin – Stability And Resin Life Cycle
11/4/2026
Protein A resin lifetime drives resin volume and process cost. Repeated caustic cleaning and regeneration cycles test whether binding capacity and impurity clearance hold up across competing resins.
-
Difficult-To-Purify And Difficult-To-Filter Small Molecules
11/3/2026
Poor filterability and stubborn impurities often trace back to the same molecular features, which changes how development teams approach scale-up for larger, structurally complex small molecules.
-
Selecting The Right Chromatography Strategy
11/3/2026
Difficult small molecule purifications rarely yield to one technique. Modeling, fraction mapping, and preparative HPLC each solve a different problem, and the right choice depends on the molecule.
-
Choosing The Right CDMO For Substance Development And Manufacturing
11/3/2026
Controlled substance programs demand licensing, closed-system custody, and inspection history well beyond GMP. Sponsors weighing partners must test technical depth against compliance infrastructure.
-
Optimizing Particle Properties For Difficult Small Molecules
11/3/2026
Crystal morphology and unexpected solid-state intermediates often decide whether a difficult small molecule filters, dries, and scales. Thermodynamic stability may not be the right target.
-
Bioconjugation Scale-Up: Data-Driven Strategies From 10 L To 500 L
10/23/2026
Data-driven scale-up of ADC bioconjugation depends on matching mixing and temperature conditions. Solvent compatibility of single-use components and production-scale economics round out the decisions.